top of page
Browse by category
Search
AUDACITY Trial: Low rate of serious adverse events supports favourable safety profile of the Allurion Balloon
Allurion Technologies has revealed topline results - from the AUDACITY Food & Drug Administration (FDA) pivotal trial evaluating the...
Allurion submits 1st of three PMA modules to FDA
Allurion Technologies has submitted the first three modules of its premarket approval application (PMA) to the FDA for the Allurion...
Allurion completes AUDACITY trial enrolment for Allurion Balloon
Allurion Technologies has completed patient enrolment in its AUDACITY trial, a randomised, pivotal controlled trial designed to support...
Browse by tag
bottom of page